Zobrazeno 1 - 10
of 175
pro vyhledávání: '"L. Roesch"'
Autor:
F. Roesch-Dietlen, A.G. Pérez-Morales, P. Grube-Pagola, M. González-Santes, F. Díaz-Roesch, A. Triana-Romero, L. Roesch-Ramos, J.M. Remes-Troche, M. Cruz-Aguilar
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 88, Iss 3, Pp 225-231 (2023)
Introduction: Metabolic (dysfunction) associated fatty liver disease (MAFLD) and gallstone disease are entities that share similar risk factors. Numerous publications confirm their elevated frequency, but few studies have considered their prevalence
Externí odkaz:
https://doaj.org/article/cd4f9de5b95c4cd8a83f4c4e0651cd92
Autor:
F. Roesch-Dietlen, A.G. Pérez-Morales, P. Grube-Pagola, M. González-Santes, F. Díaz-Roesch, A. Triana-Romero, L. Roesch-Ramos, J.M. Remes-Troche, M. Cruz-Aguilar
Publikováno v:
Revista de Gastroenterología de México, Vol 88, Iss 3, Pp 225-231 (2023)
Resumen: Introducción: La esteatosis hepática metabólica (EHMet) y la colelitiasis son entidades que comparten factores de riesgo similares. Numerosas publicaciones confirman su elevada frecuencia, sin embargo, pocos estudios han considerado su pr
Externí odkaz:
https://doaj.org/article/8b90a29a01624eb5b2538c7ffa9e6e81
Autor:
F. Roesch-Dietlen, A.G. Pérez-Morales, P. Grube-Pagola, M. González-Santes, F. Díaz-Roesch, A. Triana-Romero, L. Roesch-Ramos, J.M. Remes-Troche, M. Cruz-Aguilar
Publikováno v:
Revista de Gastroenterología de México.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94d147e9f236c89f0f7d461abd9596b3
https://doi.org/10.1016/j.rgmx.2021.09.003
https://doi.org/10.1016/j.rgmx.2021.09.003
Publikováno v:
BioTechniques, Vol 42, Iss 3, Pp 378-381 (2007)
MicroRNA (miRNA) expression profiling is a powerful and commonly used methodology for assessing the relative levels of individual miRNAs in specific tissues. To achieve accurate results using miRNA microarray detection strategies, it is important tha
Externí odkaz:
https://doaj.org/article/75bc8a2ca0f745b89475f77687561d79
Autor:
Stephen L Roesch, Amanda M Styer, G Craig Wood, Zachary Kosak, Jamie Seiler, Peter Benotti, Anthony T Petrick, Jon Gabrielsen, William E Strodel, Glenn S Gerhard, Christopher D Still, George Argyropoulos
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116928 (2015)
Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating levels correlate with each other or whether the associated hepatic signaling mechanisms that
Externí odkaz:
https://doaj.org/article/94093b34952944a89f467b2593ba91be
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85558 (2014)
BACKGROUND: The enterohepatic pathway involving the fibroblast growth factor 19 (FGF19) and bile acids (BA) has been linked with the etiology and remission of type 2 diabetes (T2D) following Roux-en-Y gastric bypass (RYGB) surgery. Specifically, diab
Externí odkaz:
https://doaj.org/article/4f984707172f4fe4ac8e43dc4faeac1a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David D. K. Rolston, David J. Carey, Anthony T. Petrick, A Yavorek, Jon Gabrielsen, Amanda M. Styer, Glenn S. Gerhard, G C Wood, Christopher D. Still, William E. Strodel, Anna Ibele, George Argyropoulos, Stephen L. Roesch, Peter N. Benotti
Publikováno v:
International journal of obesity (2005)
Objective The goal of the present study was to identify differences in gene expression between SAT, VAT, and EAT depots in Class III severely obese individuals. Design Human subcutaneous (SAT) and visceral (VAT) adipose tissues exhibit differential g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7e4243781528aa127dea4fd9eece3c
http://europepmc.org/articles/PMC3925764
http://europepmc.org/articles/PMC3925764
Autor:
William E. Strodel, Anthony T. Petrick, Glenn S. Gerhard, Stephen L. Roesch, G. Craig Wood, Jon Gabrielsen, Amanda M. Styer, George Argyropoulos, Christopher D. Still
Publikováno v:
Diabetes Care
OBJECTIVE Roux-en-Y gastric bypass (RYGB) in humans can remit type 2 diabetes, but the operative mechanism is not completely understood. In mice, fibroblast growth factor (FGF) 15 (FGF19 in humans) regulates hepatic bile acid (BA) production and can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf89ac08ba2f31b57aa358a16d64247
https://doi.org/10.2337/dc12-2255
https://doi.org/10.2337/dc12-2255